PAYNE DREWELOW: Open Payments
NPI 1962079418 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,096 in 83 payments from 15 companies in 2025. Trend: 2023 $1,659 · 2024 $2,785 · 2025 $2,096
Food & beverage: $2,042Education: $54
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $449 |
| Janssen Biotech, Inc. | 11 | $209 |
| Madrigal Pharmaceuticals | 5 | $201 |
| Ipsen Biopharmaceuticals, Inc | 3 | $193 |
| Regeneron Healthcare Solutions, Inc. | 5 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $134 |
| Celltrion USA Inc. | 2 | $132 |
| PFIZER INC. | 7 | $129 |
| Lilly USA, LLC | 5 | $110 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $108 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, REZDIFFRA, IQIRVO, RINVOQ, ZYMFENTRA, OMVOH.
Industry payments across FL — which companies pay providers there.
